Division of Anesthesiology, Pain, and Intensive Care, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel.
Department of Cardiology, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel.
J Clin Anesth. 2015 Aug;27(5):385-90. doi: 10.1016/j.jclinane.2015.03.025. Epub 2015 Apr 24.
Aortic stenosis is one of the most common valvular lesions. Nowadays, a new treatment is emerging: the transcatheter aortic valve implantation (TAVI). It is considered a suitable alternative for the surgical approach in selected high-risk patients. This procedure may be performed under sedation (SED) or under general anesthesia (GEA).
Assess the feasibility and safety of TAVI under sedation.
Observational study.
Single-center study conducted between the years 2009 and 2012.
A total of 204 American Society of Anesthesiologists physical status 3 to 4 patients who underwent TAVI in the study period and for whom complete data were obtained were included. Demographic and periprocedural data were acquired from the patients' files. The patients were divided into SED and GEA groups.
The study was not an interventional study.
The study did not include measurements.
The 2 groups had similar demographic characteristics and echocardiographic parameters. The rate of conversion from SED to GEA was 4.6%. The SED group received significantly less catecholamines and intravenous fluids during the procedure. The total procedural time was significantly shorter for the SED group. There was a trend toward more postprocedural pulmonary complications in the GEA group. In-hospital mortality and total length of stay were similar between the groups.
The results of the current study, which included a relatively large number of patients, suggest that both anesthetic modalities are safe for patients undergoing TAVI. The anesthesiologist should thus tailor the anesthetic approach to the patient, taking into account the team's experience as well as the hemodynamic status of the patient. With growing experience, our team recommends performing TAVI under SED and in selected cases under GEA.
主动脉瓣狭窄是最常见的瓣膜病变之一。如今,一种新的治疗方法正在出现:经导管主动脉瓣植入术(TAVI)。对于选定的高危患者,它被认为是手术方法的合适替代方法。该程序可以在镇静(SED)或全身麻醉(GEA)下进行。
评估镇静下 TAVI 的可行性和安全性。
观察性研究。
在 2009 年至 2012 年间进行的单中心研究。
共纳入 204 名美国麻醉医师协会身体状况 3 至 4 级的患者,这些患者在研究期间接受了 TAVI,并且获得了完整的数据。从患者档案中获取人口统计学和围手术期数据。患者分为 SED 和 GEA 组。
该研究不是干预性研究。
该研究不包括测量。
两组患者的人口统计学特征和超声心动图参数相似。SED 组转为 GEA 组的比例为 4.6%。SED 组在手术过程中接受的肾上腺素和静脉输液明显较少。SED 组的总手术时间明显更短。GEA 组术后肺部并发症的趋势更多。两组的住院死亡率和总住院时间相似。
目前的研究结果包括相当数量的患者,表明两种麻醉方式对接受 TAVI 的患者都是安全的。麻醉师应根据患者的情况,考虑团队的经验以及患者的血流动力学状态,为患者量身定制麻醉方法。随着经验的增加,我们的团队建议在镇静下进行 TAVI,并在选定的情况下在 GEA 下进行。